CNS pipeline · person
Mark Saad
Director of Axsome Therapeutics since December 2014. He is CEO of NuLids, LLC and was formerly Chief Financial Officer of Cytori Therapeutics and Executive Director at UBS Investment Bank; he holds a BA from Villanova University.
- 1 company
Current roles
- Axsome Therapeutics, Inc.Director · Board2014–present
Appears with
People sharing a company with Mark.
- Ari Maizel · Axsome Therapeutics, Inc.
- Dan Iosifescu · Axsome Therapeutics, Inc.
- Herriot Tabuteau · Axsome Therapeutics, Inc.
- Hunter Murdock · Axsome Therapeutics, Inc.
- Mark Coleman · Axsome Therapeutics, Inc.
- Mark Jacobson · Axsome Therapeutics, Inc.
- Maurizio Fava · Axsome Therapeutics, Inc.
- Nick Pizzie · Axsome Therapeutics, Inc.
- Roger Jeffs · Axsome Therapeutics, Inc.
- Susan Mahony · Axsome Therapeutics, Inc.
- Thomas Laughren · Axsome Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.